Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 6, 2018
[Transfusion independence achieved with pomalidomide therapy in a patient with primary myelofibrosis]Yoko Edahiro, Akihiko Gotoh, Tadaaki Inano, et al.International Journal of Hematology|May 21, 2025
Ropeginterferon-α2b discontinuation after long-term exposure: four cases from a single institutionShuichi Shirane, Tadaaki Inano, Yasutaka Fukuda, et al.Case Reports in Oncology|February 21, 2025
Splenic Irradiation Preceding Allogeneic Hematopoietic Stem Cell Transplantation as a Possible Risk Factor of Sinusoidal Obstruction Syndrome: A Report of Three CasesShuichi Shirane, Hajime Yasuda, Ayana Uchimura, et al.Case Reports in Oncology|February 28, 2022
Abnormal Exacerbation of Moderately Differentiated Gastric Adenocarcinoma in a Patient with TAFRO Syndrome: An Impaired Tumor Immunity?Tadaaki Inano, Hajime Yasuda, Yutaka Tsukune, et al.Frontiers in Immunology|February 9, 2024
Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two casesChiho Furuya, Hajime Yasuda, Makoto Hiki, et al.British Journal of Haematology|November 3, 2023
Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patientsChiho Furuya, Soji Morishita, Yoshinori Hashimoto, et al.Hematology (Amsterdam, Netherlands)|June 28, 2023
MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in JapanChiho Furuya, Yoshinori Hashimoto, Soji Morishita, et al.Journal of Thrombosis and Thrombolysis|December 9, 2022
Reevaluation of cardiovascular risk factors for thrombotic events in 580 Japanese patients with essential thrombocythemiaChiho Furuya, Yoshinori Hashimoto, Soji Morishita, et al.European Journal of Haematology|April 13, 2019
Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in JapanYoko Edahiro, Marito Araki, Tadaaki Inano, et al.International Journal of Hematology|January 3, 2021
Clinical impacts of the mutational spectrum in Japanese patients with primary myelofibrosisSoji Morishita, Tomonori Ochiai, Kyohei Misawa, et al.Pageof 3